rs17110436
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_013989.5(DIO2):c.*3699G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.036 in 152,196 control chromosomes in the GnomAD database, including 330 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.036   (  330   hom.,  cov: 32) 
 Exomes 𝑓:  0.0   (  0   hom.  ) 
 Failed GnomAD Quality Control 
Consequence
 DIO2
NM_013989.5 3_prime_UTR
NM_013989.5 3_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.64  
Publications
1 publications found 
Genes affected
 DIO2  (HGNC:2884):  (iodothyronine deiodinase 2) The protein encoded by this gene belongs to the iodothyronine deiodinase family. It catalyzes the conversion of prohormone thyroxine (3,5,3',5'-tetraiodothyronine, T4) to the bioactive thyroid hormone (3,5,3'-triiodothyronine, T3) by outer ring 5'-deiodination. This gene is widely expressed, including in thyroid and brain. It is thought to be responsible for the 'local' production of T3, and thus important in influencing thyroid hormone action in these tissues. It has also been reported to be highly expressed in thyroids of patients with Graves disease, and in follicular adenomas. The intrathyroidal T4 to T3 conversion by this enzyme may contribute significantly to the relative increase in thyroidal T3 production in these patients. This protein is a selenoprotein containing the non-standard amino acid, selenocysteine (Sec), which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Unlike the other two members (DIO1 and DIO3) of this enzyme family, the mRNA for this gene contains an additional in-frame UGA codon that has been reported (in human) to function either as a Sec or a stop codon, which can result in two isoforms with one or two Sec residues; however, only the upstream Sec (conserved with the single Sec residue found at the active site in DIO1 and DIO3) was shown to be essential for enzyme activity (PMID:10403186). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2018] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.121  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0358  AC: 5449AN: 152078Hom.:  326  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
5449
AN: 
152078
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF:  0.00  AC: 0AN: 6Hom.:  0  Cov.: 0 AF XY:  0.00  AC XY: 0AN XY: 2 
GnomAD4 exome 
Data not reliable, filtered out with message: AC0
 AF: 
AC: 
0
AN: 
6
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
0
AN XY: 
2
African (AFR) 
AC: 
0
AN: 
0
American (AMR) 
AC: 
0
AN: 
0
Ashkenazi Jewish (ASJ) 
AC: 
0
AN: 
0
East Asian (EAS) 
AC: 
0
AN: 
0
South Asian (SAS) 
AC: 
0
AN: 
0
European-Finnish (FIN) 
AC: 
0
AN: 
0
Middle Eastern (MID) 
AC: 
0
AN: 
0
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
6
Other (OTH) 
AC: 
0
AN: 
0
GnomAD4 genome  0.0360  AC: 5475AN: 152196Hom.:  330  Cov.: 32 AF XY:  0.0347  AC XY: 2585AN XY: 74420 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
5475
AN: 
152196
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2585
AN XY: 
74420
show subpopulations 
African (AFR) 
 AF: 
AC: 
5157
AN: 
41504
American (AMR) 
 AF: 
AC: 
210
AN: 
15290
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
3
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10592
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
50
AN: 
68008
Other (OTH) 
 AF: 
AC: 
53
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 241 
 482 
 723 
 964 
 1205 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 54 
 108 
 162 
 216 
 270 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
42
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.